Is vascular endothelial growth factor a useful biomarker in giant cell arteritis? - Wikidata - awgldk - TriplyDB

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?

http://www.wikidata.org/entity/Q37728301

about

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?

http://www.wikidata.org/entity/Q37728301

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?

@en

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?

@nl

type

label

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?

@en

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?

@nl

prefLabel

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?

@en

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?

@nl

P1433

Q37728301-00D249EB-FC78-4C8B-AEEF-45B73D8F8AA2

P1476

Q37728301-BBD27C9C-14A0-4372-AD36-7F870682C554

P2093

Q37728301-1B686583-02C5-4FAD-BEC5-9499404FC761

Q37728301-1D3BFED1-557F-4AFB-98C9-03385C4A8024

Q37728301-2C098192-A112-4D7F-8CF3-A63325A20C02

Q37728301-3803F337-A3CE-4FBD-9F3D-DFFEB87328A9

Q37728301-721174CB-4114-4FD9-A32E-1165DE442322

Q37728301-A851D498-BD5A-4F44-AAA1-D71CD66F3934

Q37728301-B7C16079-EC04-402B-AB46-B852C273E73C

Q37728301-EBC399CB-25C0-44AC-95A1-E30F74210000

Q37728301-F56EDCFC-3135-4BC8-8CDB-AE138BC53952

Q37728301-F9BBE9AB-53D0-4A49-B79B-7E230A085605

P2860

Q37728301-18380E56-FAB5-4D23-BF32-2CDFABD67DE9

Q37728301-1DD83490-271E-4DD8-B0FE-CD07613EC1EA

Q37728301-4290C8C1-FF6E-4A1C-A6E8-FC4F99628609

Q37728301-50A1AD10-AF8C-4AE9-9B13-87D76C3EA136

Q37728301-580D28C6-8CB5-439B-89E9-901F5C9822AF

Q37728301-5E750C65-37B5-4A45-A70F-7CB3BC8813BA

Q37728301-6432ACBD-44AE-413B-962C-387F77506E29

Q37728301-6678A507-3902-4DBB-A718-6B70B596BEEF

Q37728301-6AA63539-C49B-4352-B044-956C460B6849

Q37728301-6BB529F5-7DF1-494B-B02A-EF1F8ADA8054

P304

Q37728301-141D705F-F8ED-4C56-B3E1-8CB19D018864

P31

Q37728301-FD81D27A-CC07-4F60-B889-ABE0BC379B7A

P356

Q37728301-9026185E-BCE6-4360-A19F-EBB1106B7FEE

P433

Q37728301-9B62A59C-42F8-47DA-9A0B-FDBA0A59A0C5

P478

Q37728301-4EDE73D2-121C-46D8-9C82-5292B0989E8B

P577

Q37728301-0885D816-3929-497E-8600-CA1A3C82488F

P698

Q37728301-524F1083-0021-47BF-9788-9D5C15691D49

P921

Q37728301-7EC3B13D-4FCD-4D54-BE28-A88472316FE5

Q37728301-D9D80148-1EBD-4F2A-A575-74C3B556A472

P932

Q37728301-052E58DD-F09E-4B5A-9501-0B31E25A1780

P356

RMDOPEN-2016-000353

P1433

P1476

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?

@en

P2093

Afsie Sabokbar

http://www.w3.org/2001/XMLSchema#string

Allahdad Zarei

http://www.w3.org/2001/XMLSchema#string

Andrew Hutchings

http://www.w3.org/2001/XMLSchema#string

Jana Vaskova

http://www.w3.org/2001/XMLSchema#string

Julien Morlet

http://www.w3.org/2001/XMLSchema#string

Nicola Goodfellow

http://www.w3.org/2001/XMLSchema#string

Raashid Luqmani

http://www.w3.org/2001/XMLSchema#string

Shauna Masters

http://www.w3.org/2001/XMLSchema#string

Surjeet Singh

http://www.w3.org/2001/XMLSchema#string

Vanshika Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation.

Does this patient have temporal arteritis?

Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome.

Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l'Artérite à Cellules Géantes.

Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.

Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells

Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis.

Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.

P304

e000353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/RMDOPEN-2016-000353

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28405470

http://www.w3.org/2001/XMLSchema#string

P921

P932

5372063

http://www.w3.org/2001/XMLSchema#string